USTEKINUMAB

67453 reported adverse events

Drug classes: Interleukin-12 Antagonist [EPC] Interleukin-23 Antagonist [EPC]

These side effects are most commonly reported by patients taking USTEKINUMAB:

# Side effect Count
0 DRUG INEFFECTIVE 9543
1 OFF LABEL USE 7112
2 PSORIASIS 5137
3 PRODUCT USE ISSUE 3975
4 FATIGUE 3302
5 CROHN^S DISEASE 3217
6 PRODUCT DOSE OMISSION ISSUE 3093
7 PAIN 3034
8 ARTHRALGIA 2861
9 HEADACHE 2722
See all common reactions for USTEKINUMAB

USTEKINUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SWOLLEN JOINT COUNT INCREASED 380 0.5928
1 RED BLOOD CELL SEDIMENTATION RATE 121 0.5402
2 RHEUMATIC FEVER 462 0.4868
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 59 0.4720
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1366 0.4354
5 RHEUMATOID FACTOR POSITIVE 1211 0.4176
6 DEEP VEIN THROMBOSIS POSTOPERATIVE 66 0.3099
7 DUODENAL ULCER PERFORATION 686 0.2451
8 RETINITIS 126 0.2242
9 CONTRAINDICATION TO VACCINATION 38 0.2235
See all enriched reactions for USTEKINUMAB